Dupixent (dupilumab)

pCPA File Number: 22496

Negotiation Status:

Under consideration for negotiation

Indication(s):

Atopic dermatitis, pediatrics

Sponsor/Manufacturer:

Sanofi Genzyme

CDA-AMC Project Number:

SR0774-000

pCPA Engagement Letter Issued:

Not Applicable

Negotiation Process Concluded:

Not Applicable